Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors
Clinical trial NCT04812509 · COMPLETED
Trial details
- NCT number
- NCT04812509
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-20
- Primary completion
- 2021-04-29
- Enrollment
- 708
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.